首页 | 本学科首页   官方微博 | 高级检索  
检索        

鞘内注射甲泼尼龙对不完全脊髓损伤康复的疗效分析
引用本文:张弛,李幼德,张海林,杨新华,叶斌.鞘内注射甲泼尼龙对不完全脊髓损伤康复的疗效分析[J].蚌埠医学院学报,2020,45(5):599-600,605.
作者姓名:张弛  李幼德  张海林  杨新华  叶斌
作者单位:1.上海市第一康复医院骨科, 2000902.云南圣约翰医院 骨科, 云南 昆明 650228
摘    要:目的探讨蛛网膜下腔注射甲泼尼龙后对脊髓损伤后康复效果的影响。方法选取颈脊髓损伤后不完全截瘫行康复治疗的病人 131例,随机分为观察组 68 例和对照组 63例。2组病人均接受普通康复治疗。观察组在普通康复治疗基础上,接受蛛网膜下腔注射甲泼尼龙治疗。治疗前后按美国脊髓损伤协会(ASIA)标准对2组病人进行评估。结果治疗前2组病人ASIA 评分差异无统计学意义 (P>0.05)。治疗后8周,2组ASIA评分均明显高于治疗前(P<0.01),且观察组评分明显高于对照组(P<0.01)。结论甲泼尼龙鞘内注射有助于提高脊髓损伤病人的康复疗效。

关 键 词:不完全脊髓损伤    甲泼尼龙    康复    鞘内注射
收稿时间:2017-11-02

Efficacy of the intrathecal injection of methylprednisolone in the rehabilitation of incomplete spinal cord injury
Institution:1.Department of Orthopaedics, Shanghai First Rehabilitation Hospital, Shanghai 2000902.Department of Orthopaedics, Yunnan St. John's Hospital, Kunming Yunnan 650228, China
Abstract:ObjectiveTo observe the effects of intrathecal injection of methylprednisolone in the rehabilitation of incomplete spinal cord injury.MethodsOne hundred and thirty-one incomplete paraplegia patients with spinal cord injury were randomly divided into the observation group(68 cases) and control group(63 cases).Two groups were treated with the common rehabilitation method, and the observation group was additionally treated with intrathecal injection of methylprednisolone.Two groups were evaluated before and after treatment according to the American Spinal Injury Association(ASIA) criteria.ResultsThere was no statistical significance in ASIA score between two groups before treatment(P>0.05).After 8 weeks of treatment, the ASIA scores in two groups were significantly higher than that before treatment(P<0.01), and the scores in observation group were significantly higher than those in the control group(P<0.01).ConclusionsThe intrathecal injection of methylprednisolone can significantly improve the postoperative rehabilitation effects in patients with spinal cord injury.
Keywords:
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号